StockData
Merck & Co., Inc. logo

Merck & Co., Inc. (MRK) operating KPIs

MRKNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026Score 9/30242% above fair value
$146.33+5.40 (+3.83%)

Close on Oct 29, 2026Market cap $361.02BP/E 117.1Yield 2.24%

Merck consolidated EMEA Revenue ($M) ($M)

Postgres DB segment_values

QuarterlyAnnual
Latest, Q2 2026
3,920
Period ended Jun 30, 2026
Change on a year earlier
+7.1%
3,659 in Q2 2025
History
38 quarters
Since Q1 2017
Sources
29
Documents cited below

Quarterly history

Hover a value to see the sentence it was read from; calculated values show their formula

PeriodEndedConsolidated EMEA Revenue ($M) ($M)Year on yearSource
Q2 2026Jun 30, 20263,920+7.1%Form 10-Q (filed 2026-08-07) ↗
Q1 2026Mar 31, 20263,886+12.5%Form 10-Q (filed 2026-05-04) ↗
Q4 2025Dec 31, 20253,791+12.2%Form 10-K (filed 2026-02-24) ↗
Q3 2025Sep 30, 20253,680+2.7%Form 10-Q (filed 2025-11-05) ↗
Q2 2025Jun 30, 20253,659+4.1%Form 10-Q (filed 2025-08-05) ↗
Q1 2025Mar 31, 20253,454-3.1%Form 10-Q (filed 2025-05-02) ↗
Q4 2024Dec 31, 20243,380+3.2%Form 10-K (filed 2025-02-25) ↗
Q3 2024Sep 30, 20243,583+7.7%Form 10-Q (filed 2024-11-06) ↗
Q2 2024Jun 30, 20243,515+5.0%Form 10-Q (filed 2024-08-05) ↗
Q1 2024Mar 31, 20243,563+7.9%Form 10-Q (filed 2024-05-03) ↗
Q4 2023Dec 31, 20233,276+0.3%Form 10-K (filed 2024-02-26) ↗
Q3 2023Sep 30, 20233,327+1.2%Form 10-Q (filed 2023-11-03) ↗
Q2 2023Jun 30, 20233,348-6.5%Form 10-Q (filed 2023-08-07) ↗
Q1 2023Mar 31, 20233,303-24.2%Form 10-Q (filed 2023-05-05) ↗
Q4 2022Dec 31, 20223,265-4.8%Form 10-K (filed 2023-02-24) ↗
Q3 2022Sep 30, 20223,286-1.7%Form 10-Q (filed 2022-11-03) ↗

Cite this data

StockData. (2026). Merck Consolidated EMEA Revenue ($M) ($M), quarterly Q1 2017–Q2 2026 [Data set]. Compiled from Merck SEC filings and investor materials. https://stockdatahq.com/stocks/mrk/kpis/db_geo_emea_rev

See every metric in the Merck KPI table. Data updated Oct 26, 2026.